News Agencies Feed

healthcare

Nov 13

NMC Healthcare Walkathon 2018

NMC Healthcare Walkathon 2018

November is National Diabetes Awareness Month. 2,000 participants let their legs do the talking as they joined NMC’s Walkathon yesterday.

Organised by NMC Royal Medical Center, Ras Al Khaimah in association"...

Continue Reading >>

Nov 11

NMC Healthcare wins at this year’s Bonds, Loans & Sukuk Awards, Middle East

NMC Healthcare wins at this year’s Bonds, Loans & Sukuk Awards, Middle East

NMC Healthcare was awarded the prestigious Leveraged Finance Deal of the Year at Bonds, Loans & Sukuk Awards which took place last week.

Organised by GFC Group, Bonds, Loans & Sukuk Awards, Middle East,"...

Continue Reading >>

Nov 10

Team of specialists at Al Zahra Hospital get together to save the foot of a 42-year old Patient

Team of specialists at Al Zahra Hospital get together to save the foot of a 42-year old Patient

Recently, a team of doctors at Al Zahra Hospital Sharjah were tasked with treating a 42-year-old patient; Ahmed Mansouri, name changed for confidentiality purpose, who was a long-term diabetic. The patient had developed severe infections in both feet. His left foot in particular had suffered"...

Continue Reading >>

Nov 07

NMC Royal Medical Centre to Host Walkathon to Combat Diabetes

NMC Royal Medical Centre to Host Walkathon to Combat Diabetes

In an effort to raise awareness about diabetes, NMC Royal Medical Centre, Ras Al Khaimah in association with Ras Al Khaimah Police and the Ras Al Khaimah Public Services Department to organise a walkathon on November 9th, 2018 for World Diabetes Day.

NMC"...

Continue Reading >>

Nov 06

ResMed to Acquire MatrixCare, Expands Out-of-Hospital SaaS Portfolio into Long-Term Care Settings

ResMed to Acquire MatrixCare, Expands Out-of-Hospital SaaS Portfolio into Long-Term Care Settings

  • Expands ResMed’s out-of-hospital software portfolio into skilled nursing and senior living verticals
  • Enhances ResMed’s ability to improve patient transitions of care and provider efficiencies
  • Purchase price $750 million, accretive to non-GAAP gross margin and non-GAAP diluted earnings per share

(...

Continue Reading >>

Nov 06

Arima Genomics Completes Early Access Program and Launches the Arima-HiC Platform

Arima Genomics Completes Early Access Program and Launches the Arima-HiC Platform

(AETOS Wire)-- Arima Genomics, Inc., a biotechnology company empowering researchers to apply long-range genetic sequence and structure information toward the understanding of health, disease and species evolution, announced today the full commercial"...

Continue Reading >>

Nov 06

EKOS™ Control Unit 4.0 Simplifies Treatment of Blood Clots

EKOS™ Control Unit 4.0 Simplifies Treatment of Blood Clots

(AETOS Wire) -- BTG plc (LSE: BTG), the global healthcare company, announced today that the first EKOS™ CU 4.0 units have been shipped from BTG’s facility in Bothell (Washington, US) to Europe, where full commercial launch will begin. New"...

Continue Reading >>

Nov 05

 Kanaan: Health care card underway, funding mechanisms to be discussed on Monday

Kanaan: Health care card underway, funding mechanisms to be discussed on Monday

NNA - Finance and Budget Parliamentary Committee Head, MP Ibrahim Kanaan, assured Sunday that 'the health care card is heading towards completion,' adding that discussions over its funding mechanisms will feature high during the Committee's meeting tomorrow.

Kanaan"...

Continue Reading >>

Nov 05

Initial results from EMPRISE real-world evidence study shows empagliflozin was associated with reduced risk for hospitalisation for heart failure compared with DPP-4 inhibitors in people with type 2 diabetes with and without cardiovascular disease

Initial results from EMPRISE real-world evidence study shows empagliflozin was associated with reduced risk for hospitalisation for heart failure compared with DPP-4 inhibitors in people with type 2 diabetes with and without cardiovascular disease

(AETOS Wire)-- Initial effectiveness results from the real-world EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study showed empagliflozin was associated with a 44 percent relative risk reduction in hospitalisation for heart failure (HHF)"...

Continue Reading >>

Nov 05

U.S. Businessman Issues Global, Multimillion Dollar (USD) Challenge for Innovative Alzheimer’s Solutions

U.S. Businessman Issues Global, Multimillion Dollar (USD) Challenge for Innovative Alzheimer’s Solutions

(AETOS Wire) -- To expand the understanding and explanation of Alzheimer’s disease, United States businessman James Truchard has given a $5 million USD gift to The University of Texas at San Antonio (UTSA) College of Sciences to establish the"...

Continue Reading >>